Published in J Invest Dermatol on August 01, 1989
Epidermal Langerhans cells from normal human skin bind monomeric IgE via Fc epsilon RI. J Exp Med (1992) 1.77
Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (Fc epsilon RI). J Exp Med (1992) 1.72
Abundant immunoglobulin E-positive cells in skin lesions support an allergic etiology of atopic dermatitis in the elderly. J Eur Acad Dermatol Venereol (2012) 0.80
IgE-positive epidermal Langerhans cells in allergic contact dermatitis lesions provoked in patients with atopic dermatitis. Arch Dermatol Res (1990) 0.79
Why is the prevalence of allergic diseases increasing? A critical assessment of some classical risk factors. Mediators Inflamm (2001) 0.78
CD23/Fc epsilon R11 expression in contact sensitivity reactions: a comparison between aeroallergen patch test reactions in atopic dermatitis and the nickel patch test reaction in non-atopic individuals. Clin Exp Immunol (1993) 0.77
Cell-bound IgE and increased expression of Fc epsilon-receptors on dendritic cells in cutaneous infiltrates of mycosis fungoides. Clin Exp Immunol (1991) 0.76
Increased number of IgE positive Langerhans cells in the conjunctiva of patients with atopic dermatitis. Br J Ophthalmol (1997) 0.76
Atopic dermatitis: a paradigmatic allergic skin disease. Mediators Inflamm (2001) 0.75
Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science (1999) 21.24
Characterization of T7-specific ribonucleic acid polymerase. 1. General properties of the enzymatic reaction and the template specificity of the enzyme. J Biol Chem (1973) 5.42
A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy (2001) 5.07
puckered encodes a phosphatase that mediates a feedback loop regulating JNK activity during dorsal closure in Drosophila. Genes Dev (1998) 4.64
Genome-wide, large-scale production of mutant mice by ENU mutagenesis. Nat Genet (2000) 3.92
Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology (1997) 3.48
Characterization of T7-specific ribonucleic acid polymerase. II. Inhibitors of the enzyme and their application to the study of the enzymatic reaction. J Biol Chem (1973) 3.32
Reproducibility of patch tests. J Am Acad Dermatol (1989) 2.65
Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet (1977) 2.60
Practical guide to skin prick tests in allergy to aeroallergens. Allergy (2011) 2.51
[Skin cancer screening in Germany : The situation in 2014 with suggestions for the future]. Hautarzt (2015) 2.29
Antibody and HIV-1 gp120 recognition of CD4 undermines the concept of mimicry between antibodies and receptors. Nature (1992) 2.27
Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy (2008) 2.18
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17
A nonhuman primate model for the selective elimination of CD8+ lymphocytes using a mouse-human chimeric monoclonal antibody. Am J Pathol (1999) 2.16
Informatics and medicine--from molecules to populations. Methods Inf Med (2008) 2.13
Manifestation of atopy is not related to patient's month of birth. Allergy (1993) 2.11
Integration and transcription of mouse mammary tumor virus DNA in rat hepatoma cells. Proc Natl Acad Sci U S A (1979) 2.08
Annular erythema associated with Sjögren's syndrome: a variant of systemic lupus erythematosus. J Am Acad Dermatol (1991) 2.07
Differences in efficacy between intention-to-treat and per-protocol analyses for patients with psoriasis vulgaris and atopic dermatitis: clinical and pharmacoeconomic implications. Br J Dermatol (2001) 2.05
Traffic-related air pollution is associated with atopy in children living in urban areas. Epidemiology (2000) 2.04
The human peripheral lymphocyte--a model system for studying the combined effect of psoralen plus black light. Klin Wochenschr (1977) 1.97
The ABCD rule of dermatoscopy. High prospective value in the diagnosis of doubtful melanocytic skin lesions. J Am Acad Dermatol (1994) 1.94
[Electron microscopic studies on the dynamics of acantholysis in pemphigus vulagaris. I. The clinically normal appearing skin in the environment of blisters with a positive Nikolski phenomenon]. Arch Klin Exp Dermatol (1965) 1.94
Structural aspects of initial psoriatic lesions. Arch Dermatol Forsch (1974) 1.81
UV-induced skin changes due to regular use of commercial sunbeds. Photodermatol Photoimmunol Photomed (2002) 1.81
Standardization of food challenges in patients with immediate reactions to foods--position paper from the European Academy of Allergology and Clinical Immunology. Allergy (2004) 1.81
Successful and safe use of 2 min cold atmospheric argon plasma in chronic wounds: results of a randomized controlled trial. Br J Dermatol (2012) 1.78
Does adjunctive midazolam reduce recovery agitation after ketamine sedation for pediatric procedures? A randomized, double-blind, placebo-controlled trial. Ann Emerg Med (2000) 1.76
[Electron microscopic studies on the dynamics of acantholysis in pemphigus vulgaris. II. The acantholytic vesicle]. Arch Klin Exp Dermatol (1965) 1.75
Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (Fc epsilon RI). J Exp Med (1992) 1.72
Alternative medicine in allergies - prevalence, patterns of use, and costs. Allergy (2002) 1.72
Studies of the binding of Escherichia coli RNA polymerase to DNA. V. T7 RNA chain initiation by enzyme-DNA complexes. J Mol Biol (1972) 1.70
Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy. Br J Cancer (2007) 1.67
[Dynamics of normal and pathological hair growth]. Arch Klin Exp Dermatol (1966) 1.62
[On the problem of optimal reacting conditions in the histochemical demonstration on enzymes of the energy-delivering metabolism in the epidermis. I. Dehydrogenase]. Arch Klin Exp Dermatol (1965) 1.60
Congenital leukonychia totalis in two brothers. Acta Derm Venereol (1998) 1.58
Prevalence of overweight and obesity in East and West German children in the decade after reunification: population-based series of cross-sectional studies. J Epidemiol Community Health (2008) 1.56
[Psoriatic onycho-pachydermo- periostitis]. Z Rheumatol (2002) 1.56
General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy (2002) 1.56
Specific immunotherapy in honeybee venom allergy: a comparative study using aqueous and aluminium hydroxide adsorbed preparations. Allergy (2004) 1.56
[Microstructure of the epidermis in chronic nummular eczema. I. Stratum basale]. Arch Klin Exp Dermatol (1965) 1.54
[Postoperative adjuvant therapy with interferon alfa-2B following laser surgery of condylomata acuminata]. Hautarzt (1990) 1.54
Epidemiology of acne in the general population: the risk of smoking. Br J Dermatol (2001) 1.54
EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy (2007) 1.53
Can immunoglobulin E-measurement replace challenge tests in allergic rhinoconjunctivits to grass pollen? Clin Exp Allergy (2011) 1.51
Gender difference, sex hormones, and immediate type hypersensitivity reactions. Allergy (2008) 1.50
[Stimulation of epidermal DNA syntgesis through vitamin A acid]. Arch Klin Exp Dermatol (1968) 1.48
Clinical relevance of immunogenicity of biologics in psoriasis: implications for treatment strategies. J Eur Acad Dermatol Venereol (2014) 1.47
A first prospective randomized controlled trial to decrease bacterial load using cold atmospheric argon plasma on chronic wounds in patients. Br J Dermatol (2010) 1.45
Dithranol: a review of the mechanism of action in the treatment of psoriasis vulgaris. Skin Pharmacol (1990) 1.43
Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE). Br J Dermatol (2014) 1.43
Reducing the risk of anaphylaxis during anaesthesia: guidelines for clinical practice. J Investig Allergol Clin Immunol (2005) 1.43
Predicting side-effects in venom immunotherapy by basophil activation? Allergy (2006) 1.42
Clinical improvement in psoriasis during dithranol/UVB therapy does not correspond with a decrease in elevated serum soluble ICAM-1 levels. Arch Dermatol Res (1993) 1.42
Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma. Cancer Res (1997) 1.42
Invasion of human keratinocytes by Staphylococcus aureus and intracellular bacterial persistence represent haemolysin-independent virulence mechanisms that are followed by features of necrotic and apoptotic keratinocyte cell death. Br J Dermatol (2002) 1.42
Thyroid hormone receptors. Binding characteristics and lack of hormonal dependency for nuclear localization. J Biol Chem (1975) 1.42
The prevalence of positive reactions in the atopy patch test with aeroallergens and food allergens in subjects with atopic eczema: a European multicenter study. Allergy (2004) 1.42
Epidemiology of contact allergy in adults. Allergy (2001) 1.41
Late irradiation damage to the skin caused by soft X-ray radiation therapy of cutaneous tumors. Arch Dermatol (1995) 1.41
The renin angiotensin system and hymenoptera venom anaphylaxis. Clin Exp Allergy (1993) 1.40
In situ localization of IgG in epidermolysis bullosa acquisita by immunogold technique. J Am Acad Dermatol (1992) 1.40
[Abnormal behavior of epidermal regeneration in patients with psoriasis vulgaris]. Arch Klin Exp Dermatol (1967) 1.39
Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases. Exp Dermatol (2004) 1.39
Putative association of a TLR9 promoter polymorphism with atopic eczema. Allergy (2007) 1.39
Management of nevus spilus. Pediatr Dermatol (1999) 1.38
[Virus-specific antibody profile in various stages of HIV-1 infection. Western blot analysis of 170 patients]. Klin Wochenschr (1988) 1.38
Semiquantitative analysis of histologic criteria in thin malignant melanomas. J Am Acad Dermatol (1989) 1.38
[Epidermal regeneration of guinea pig's ear following the tearing off of the horny layer. A radioautographic study]. Arch Klin Exp Dermatol (1967) 1.38
Prognostic index in malignant melanoma. Arch Dermatol (1978) 1.36
Excisional biopsy as the first therapeutic procedure versus primary wide excision of malignant melanoma. Cancer (1989) 1.35
Skin test concentrations for systemically administered drugs -- an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy (2013) 1.33
[Inflammatory infiltrate in psoriasis vulgaris. A cytochemical study]. Arch Klin Exp Dermatol (1970) 1.33
Training phonological awareness with and without explicit attention to articulation. J Exp Child Psychol (1999) 1.33
International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies. Br J Dermatol (2003) 1.29
Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol (1996) 1.29
Treatment of rheumatoid arthritis with monoclonal CD4 antibody M-T151. Clinical results and immunopharmacologic effects in an open study, including repeated administration. Arthritis Rheum (1991) 1.28
[Current aspects of the pathogenesis of skin manifestations in psoriasis vulgaris]. Hautarzt (1976) 1.27
Involvement of the cytotoxic/suppressor T-cell subset in liver tissue injury of patients with acute and chronic liver diseases. Gastroenterology (1983) 1.26
[Modification of epidermal differentiation by vitamin A acid. Electron microscopy study]. Arch Klin Exp Dermatol (1970) 1.25
Standard skin prick testing and sensitization to inhalant allergens across Europe--a survey from the GALEN network. Allergy (2005) 1.25
Initial events in psoriasis: quantitative assessment. Br J Dermatol (1973) 1.24
A new basophil activation test using CD63 and CCR3 in allergy to antibiotics. Clin Exp Allergy (2010) 1.24
Skin testing in patients with hypersensitivity reactions to iodinated contrast media - a European multicenter study. Allergy (2009) 1.24
High local interleukin 5 production in granuloma faciale (eosinophilicum): role of clonally expanded skin-specific CD4+ cells. Br J Dermatol (2005) 1.23
The cellular receptor (CD4) of the human immunodeficiency virus is expressed on neurons and glial cells in human brain. J Exp Med (1987) 1.23
Regulated expression of cytokines in human endometrium throughout the menstrual cycle: dysregulation in habitual abortion. Mol Hum Reprod (2000) 1.23
Angiolymphoid hyperplasia with eosinophilia treated with anti-interleukin-5 antibody (mepolizumab). Br J Dermatol (2004) 1.23
Local production of interleukin-4 during radiation-induced pneumonitis and pulmonary fibrosis in rats: macrophages as a prominent source of interleukin-4. Am J Respir Cell Mol Biol (1997) 1.22
Improvement of early recognition of lentigo maligna using dermatoscopy. J Am Acad Dermatol (2000) 1.22
GA2LEN (Global Allergy and Asthma European Network) addresses the allergy and asthma 'epidemic'. Allergy (2009) 1.22
Binding to human jejunum of serum IgA antibody from children with coeliac disease. Lancet (1990) 1.22
Mechanisms of parakeratosis. Br J Dermatol (1970) 1.22
Proliferative cells in the human sebaceous gland. Labelling index and regional variations. Acta Derm Venereol (1971) 1.21
Epidemiology of food allergy/food intolerance in adults: associations with other manifestations of atopy. Allergy (2001) 1.20